Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 232-236

  Castaman, Giancarlo ^a   Tosetto, Alberto ^a   Ruggeri, Marco ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

APC resistance; Factor V; FV Leiden; Inherited thrombophilia; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGE OF ONSET; FACTOR V; FACTOR V DEFICIENCY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0032816611     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01502.x     Document Type: Article

References (22)

1. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Bertina, R.M., Reitsma, P.H., Rosendaal, F.R. & Vandenbroucke, J.P. (1995) Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thrombosis and Haemostasis, 74, 449-453.
3. Castaman, G., Lunghi, B., Missiaglia, E., Bernardi, F. & Rodeghiero, F. (1997) Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His 1299Arg substitutions in factor V. British Journal of Haematology, 99, 257-261.
4. Castoldi, E., Kalafatis, M., Lunghi, B., Simioni, P., Ioannou, P.A., Petio, M., Girolami, A., Mann, K.G. & Bernardi, F. (1998) Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for R506Q and a FV null mutation results in the exclusive presence of FV leiden molecules in plasma. Thrombosis and Haemostasis, 80, 403-406.
5. Delahousse, B., Iochmann, S., Pouplard, C., Fimbel, B., Charbonnier, B. & Gruel, Y. (1997) Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency: variable expression when analyzed by different activated protein C resistance functional assays. Blood Coagulation and Fibrinolysis, 8, 503-509.
6. de Ronde, H. & Bertina, R.M. (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thrombosis and Haemostasis. 72, 880-886.
7. Greengard, J.S., Alhenc-Gelas, M., Gandrille, S., Emmerich, J., Aiach, M. & Griffin, J. (1995) Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type 1 factor V deficiency associated with thrombosis. (Abstract). Thrombosis and Haemostasis, 73, 1361.
8. Greengard, J.S., Eichinger, S., Griffin, J.H. & Bauer, K.A. (1994) Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V. New England Journal of Medicine, 331, 1559-1562.
9. Guasch, J.F., Lensen, R.P.M. & Bertina, R.M. (1997) Molecular characterization of a type 1 quantitative factor V deficiency in a thrombosis patient that is 'pseudohomozygous' for activated protein C resistance. Thrombosis and Haemostasis, 77, 252-257.
10. Hille, E.T., Westendorp, R.G., Vandenbroucke, J.P. & Rodendaal, F.R. (1997) Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood, 89, 1963-1967.
11. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistic Association, 53, 457-481.
12. Kleinbaum, D.G., Kupper, L.L. & Morgenstern, H. (1982) Epidemiologic Research. Lifetime Learning Publications, Belmont, Ca.
13. Lensen, R.P.M., Rosendaal, F.R., Koster, T., Allaart, C.F., de Ronde, H., Vandenbroucke, J.P., Reitsma, P.H. & Bertina, R.M. (1996) Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood, 88, 4205-4208.
14. Lunghi, B., Castoldi, E., Mingozzi, F., Bernardi, F. & Castaman, G. (1998) A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject. Blood, 92, 1463-1464.
15. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
16. Rodeghiero, F. & Tosetto, A. (1996) The VITA project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen: relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, 226-233.
17. Rodeghiero, F. & Tosetto, A. (1997) The epidemiology of inherited thrombophilia: the VITA project. Thrombosis and Haemostasis, 78, 636-640.
18. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. & Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504-1508.
19. Simioni, P., Scudeller, A., Radossi, P., Gavasso, S., Girolami, B., Tormene, D. & Girolami, A. (1996) 'Pseudohomozygous' activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type 1 quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thrombosis and Haemostasis, 75, 422-426.
20. Tosetto, A. & Rodeghiero, F. (1995) Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thrombosis and Haemostasis, 73, 732-733.
21. Zoller, B., Svensson, P.J., He, X. & Dahlbäck, B. (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation, 94, 2521-2524.
22. Zehnder. J.L. & Jain, M. (1996) Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. Blood Coagulation and Fibrinolysis, 7, 361-362.